FILE PHOTO: A Sanofi sign outside the French drugmaker’s Paris headquarters, October 30, 2014. REUTERS/Christian Hartmann//File Photo
BOSTON (Reuters) – Sanofi SA (SASY.PA) has agreed to pay nearly $11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.
The U.S. Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers’ financial support of patient assistance charities.
Sanofi did not admit wrongdoing as part of the settlement.
Reporting by Nate Raymond in Boston; Editing by Sandra Maler
Our Standards:The Thomson Reuters Trust Principles.
